Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Wave Life Sciences Ltd.
DescriptionAllele-specific antisense therapy targeting rs362307
Molecular Target
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPreclinical
Standard IndicationHuntington's disease (HD)
Indication DetailsTreat Huntington's disease (HD)
Regulatory Designation U.S. - Orphan Drug (Treat Huntington's disease (HD))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today